121 related articles for article (PubMed ID: 27185639)
21. Autoimmune diseases: targets, biology, and drug discovery.
Li SJ; Wu YL; Chen JH; Shen SY; Duan J; Xu HE
Acta Pharmacol Sin; 2024 Apr; 45(4):674-685. PubMed ID: 38097717
[TBL] [Abstract][Full Text] [Related]
22. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
[TBL] [Abstract][Full Text] [Related]
23. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance.
Baekkeskov S
Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081
[TBL] [Abstract][Full Text] [Related]
25. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
van Lummel M; Zaldumbide A; Roep BO
Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
[TBL] [Abstract][Full Text] [Related]
26. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
[TBL] [Abstract][Full Text] [Related]
27. Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
Ronkainen MS; Hoppu S; Korhonen S; Simell S; Veijola R; Ilonen J; Simell O; Knip M
Eur J Endocrinol; 2006 Oct; 155(4):633-42. PubMed ID: 16990664
[TBL] [Abstract][Full Text] [Related]
28. Influence of maternal hyperglycaemia on cord blood mononuclear cells in response to diabetes-associated autoantigens.
Stechova K; Spalova I; Durilova M; Bartaskova D; Cerny M; Cerna M; Pithova P; Chudoba D; Stavikova V; Ulmannova T; Faresjö M
Scand J Immunol; 2009 Aug; 70(2):149-58. PubMed ID: 19630921
[TBL] [Abstract][Full Text] [Related]
29. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
[TBL] [Abstract][Full Text] [Related]
30. Autoantigen microarrays for multiplex characterization of autoantibody responses.
Robinson WH; DiGennaro C; Hueber W; Haab BB; Kamachi M; Dean EJ; Fournel S; Fong D; Genovese MC; de Vegvar HE; Skriner K; Hirschberg DL; Morris RI; Muller S; Pruijn GJ; van Venrooij WJ; Smolen JS; Brown PO; Steinman L; Utz PJ
Nat Med; 2002 Mar; 8(3):295-301. PubMed ID: 11875502
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
[TBL] [Abstract][Full Text] [Related]
32. GAD65 as a prototypic autoantigen.
Fenalti G; Rowley MJ
J Autoimmun; 2008 Nov; 31(3):228-32. PubMed ID: 18514483
[TBL] [Abstract][Full Text] [Related]
33. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
34. Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.
Park H; Yu L; Kim T; Cho B; Kang J; Park Y
Ann N Y Acad Sci; 2006 Oct; 1079():213-9. PubMed ID: 17130557
[TBL] [Abstract][Full Text] [Related]
35. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
36. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
[TBL] [Abstract][Full Text] [Related]
37. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
38. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
[TBL] [Abstract][Full Text] [Related]
39. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
40. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against type 1 diabetes.
Geenen V; Mottet M; Dardenne O; Kermani H; Martens H; Francois JM; Galleni M; Hober D; Rahmouni S; Moutschen M
Curr Opin Pharmacol; 2010 Aug; 10(4):461-72. PubMed ID: 20434402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
